Mutual of America Capital Management LLC Sells 2,935 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Mutual of America Capital Management LLC lessened its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 4.9% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 56,964 shares of the company’s stock after selling 2,935 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Acadia Healthcare were worth $4,430,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Headlands Technologies LLC purchased a new position in Acadia Healthcare during the 3rd quarter valued at about $25,000. Point72 Hong Kong Ltd purchased a new position in Acadia Healthcare during the 1st quarter valued at about $38,000. Fifth Third Bancorp grew its holdings in Acadia Healthcare by 25.5% during the 4th quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock valued at $52,000 after buying an additional 136 shares in the last quarter. Belpointe Asset Management LLC grew its holdings in Acadia Healthcare by 75.7% during the 1st quarter. Belpointe Asset Management LLC now owns 982 shares of the company’s stock valued at $71,000 after buying an additional 423 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale purchased a new position in Acadia Healthcare during the 3rd quarter valued at about $96,000.

Acadia Healthcare Stock Performance

NASDAQ:ACHC opened at $73.11 on Tuesday. The business has a 50 day moving average of $79.98 and a 200 day moving average of $77.65. The company has a market capitalization of $6.76 billion, a price-to-earnings ratio of -292.43, a PEG ratio of 2.16 and a beta of 1.31. Acadia Healthcare Company, Inc. has a 1-year low of $66.49 and a 1-year high of $87.77. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.67 and a quick ratio of 0.67.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Wednesday, February 28th. The company reported $0.85 earnings per share for the quarter, topping analysts’ consensus estimates of $0.80 by $0.05. The company had revenue of $742.80 million during the quarter, compared to the consensus estimate of $727.60 million. Acadia Healthcare had a positive return on equity of 11.21% and a negative net margin of 0.74%. Acadia Healthcare’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.70 EPS. On average, sell-side analysts predict that Acadia Healthcare Company, Inc. will post 3.57 earnings per share for the current fiscal year.

Insider Buying and Selling at Acadia Healthcare

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of the business’s stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total value of $188,114.17. Following the completion of the sale, the director now owns 46,074 shares in the company, valued at $3,934,258.86. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 2.80% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on ACHC. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $90.00 target price on shares of Acadia Healthcare in a report on Tuesday, March 5th. Royal Bank of Canada reissued an “outperform” rating and set a $94.00 price objective on shares of Acadia Healthcare in a report on Monday, March 4th. Barclays assumed coverage on Acadia Healthcare in a report on Wednesday, March 6th. They set an “overweight” rating and a $100.00 price objective for the company. TheStreet raised Acadia Healthcare from a “c” rating to a “b-” rating in a report on Monday, March 4th. Finally, TD Cowen boosted their price objective on Acadia Healthcare from $86.00 to $101.00 and gave the stock an “outperform” rating in a report on Friday, March 1st. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $91.22.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.